Based on the above pathogenic effects of Lp‐PLA2 and Lp(a) on cardiovascular and cerebrovascular diseases, we hypothesis whether Lp‐PLA2 combined with Lp(a) is expected to be a better biomarker. This evidence concerns the gene LPA and cerebrovascular disorder.